Why the study?
Does the lipid accumulation product predict incident cardiovascular events better than other anthropometric indices in a normal weight population?
Does the lipid accumulation product predict incident cardiovascular events better than other anthropometric indices in a normal weight population?
While the lipid accumulation product predicts cardiovascular events in normal-weight individuals, it offers no prognostic advantage over other standard anthropometric indices.
LAP adds no advantage over standard anthropometrics for CV risk prediction in normal BMI; leaves open its role in refined models.
LAP is an independent predictor of cardiovascular events in normal BMI subjects, but is not superior over other anthropometrics indices.
No takes yet. Share an insight, caveat, or question.
Hosseinpanah et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: